A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...
The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and ...
News Medical on MSN1d
Targeted mRNA therapy shows promise for healing damaged lungsA combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
Scientists have developed a lipid nanoparticle system that enables mRNA to cross the blood-brain barrier, a long-standing challenge in n.
Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...
A new lipid nanoparticle system can deliver messenger RNA (mRNA) to the brain via intravenous injection. | Drug Discovery And ...
Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...
Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nature Materials , 2025; DOI: 10.1038/s41563-024-02114-5 Cite This Page : ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback